CLINICAL
71%
reversed type 2 diabetes
A1C below 6.5%
27 lbs
average weight loss
85%
safely reduced or stopped GLP-1s
outcomes sustained

Type 2 diabetes reversal
member still engages daily
Average weight loss
Savings per members



.avif)




Twin treats the metabolic dysfunction underneath weight gain, high blood sugar, high blood pressure, and the medications that follow. The Digital Twin Care Platform guides care based on what each person actually needs, in the moment, using patented technology. Not through disconnected programs or periodic check-ins.

Some members have no diagnosis yet. Others are on multiple medications. Twin covers both, under a single contract and a single care team.

No two people respond exactly the same way. Each AI Digital Twin continuously learns from one person’s health, habits, routines, and responses, powered by our patented technology, helping the Care Team guide what works for that individual.
Three people. Three different paths. Care built around each one.

.webp)

of Twin members on GLP-1 medication safely reduce or stop it, and continue experiencing results.
Twin improves the underlying health need, so weight-loss results hold when doses are reduced. For a plan sponsor, that is a pharmacy line that declines instead of compounding.
* Cleveland Clinic RCT, NEJM Catalyst, 2025. Individual results may vary. Medication changes are made with appropriate clinical support.

We'll model the clinical and financial impact on your population and show you the evidence behind it.
No member data required to start.